Nodthera Is A Clinical Stage Biotechnology Company Based In Bostonmawith Additional Operations In Cambridgeukand Seattlewathe Company Specializes In Developing Therapies That Target Chronic Inflammatory Diseases By Inhibiting The Nlrp3 Inflammasomea Significant Contributor To Inflammationnodthera Aims To Address Conditions Such As Obesitycardiometabolic Disordersand Neurodegenerative Diseases Through Its Innovative Approach To Precision Molecular Chemistry The Company S Lead Candidatent 0796Is An Oralsmall Molecule Nlrp3 Inflammasome Inhibitor That Has Shown Promising Anti Inflammatory Effects In Clinical Trialsit Successfully Met Its Primary Endpoint In A Phase Ib Iia Trial For Obese Patients With Cardiovascular Riskdemonstrating Its Potential As A Best In Class Therapynodthera S Focus On Brain Penetrant Properties Sets Its Candidates Apart In The Treatment Of Neuroinflammation Associated With Neurodegenerative Diseasesthe Company Is Backed By Prominent Investorsincluding 5Am Ventures And Sanofi Venturesand Has Received Recognition For Its Innovative Work In The Field
No conferences found for this company.
| Company Name | Nodthera Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
